Velarion Records
Free. Unsubscribe any time.

Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics, Inc. filed 8 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 10 transactions and 93,576 shares. None carries the SEC's AFF10B5ONE flag; all 8 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Entrada Therapeutics, Inc. 10

Adoption dates in Entrada Therapeutics, Inc. 4

Results prints in Entrada Therapeutics, Inc. 0

Trades before a print in Entrada Therapeutics, Inc. 0

Interval to Entrada Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Entrada Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on March 15, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.